Newscope Capital Corporation Stock Company Profile

Description

PharmaTher Holdings Ltd., a clinical-stage psychedelics biotech company, focuses on the research, development, and commercialization of novel uses, formulations, and delivery methods of psychedelics to treat mental illness, neurological, and pain disorders. The company's products in pipeline include Ketamine, which is in Phase I and II clinical trials for Parkinson's disease and anesthesia and procedural sedation indications, as well as in preclinical trials for ALS-Lou Gehrig's disease indications; KETABET, which is in Phase I and II clinical trials for mental health, neurological, and pain disorders; and Pychedelics. It is also developing microneedle patches. PharmaTher Holdings Ltd has collaboration agreement with CC Biotechnology Corporation to develop and commercialize novel wearable ketamine delivery device for mental health, neurological and pain disorders. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.